Obesity Associated With Sooner MS Disease Progression

WEST PALM BEACH, Fla. — Obesity in a pair of sclerosis (MS) used to be tied to sooner worsening of disability and an increased be troubled of physical, psychological, and cognitive decline, a doubtless cohort survey confirmed.

When put next with long-established weight, weight problems used to be connected to a sooner amplify in ratings on the Expanded Incapacity Situation Scale (EDSS), which ranges from 0-10 with increased numbers reflecting increased disability, reported Lars Alfredsson, PhD, of the Karolinska Institute in Stockholm, Sweden, in a presentation on the ACTRIMS Forum 2024, the annual meeting of the Americas Committee for Treatment and Study in Extra than one Sclerosis.

The be troubled of reaching EDSS 3 used to be 41% increased in MS sufferers with weight problems (hazard ratio [HR] 1.41, 95% CI 1.51-1.72). The be troubled of reaching EDSS 4 used to be 31% increased (HR 1.31, 95% 1.03-1.68).

Obesity also used to be connected to an increased be troubled of self-reported physical quality of life (HR 1.40, 95% CI 1.18-1.67) and psychological quality of life (HR 1.24, 95% CI 1.04-1.46), and with cognitive disability worsening (HR 1.47, 95% CI 1.08-2.01).

Several compare take into accout shown weight problems will most likely be a be troubled ingredient for increasing MS, but few take into accout drawn definitive conclusions about the role of weight problems in MS progression, Alfredsson noted. One most soundless survey, nonetheless, stumbled on that weight problems in newly identified MS sufferers used to be linked with a drastically increased be troubled of reaching EDSS 3 over 6 years, in contrast with long-established weight.

“Sufferers progressively quiz about strategies they might be able to affect the route of MS using daily life interventions,” said Robert Bermel, MD, of the Cleveland Clinic in Ohio, who wasn’t concerned with the survey.

“In step with this and other compare, weight loss will also be suggested as a daily life intervention for obese sufferers with MS, besides to therapy with disease-modifying therapy,” Bermel urged MedPage As we train time in an email.

He and Alfredsson also introduced up the aptitude survey of GLP-1 agonists like semaglutide (Ozempic, Wegovy) for therapeutic weight loss in sufferers with MS.

Variations in disease progression weren’t as stark for sufferers labeled as overweight, Alfredsson reported. In sufferers who did not change BMI category right via the survey duration, the variations were increased than among the many overall community, with increased dangers of reaching EDSS 3, physical and psychological worsening, and cognitive disability worsening.

The survey also stumbled on that sufferers within the overweight and weight problems teams had a a miniature increased be troubled of new lesions on MRI post-prognosis.

Data came from 3,249 sufferers within the Swedish MS Registry from 2005-2019, and from questionnaires sufferers answered at survey inclusion and later in 2021. Sufferers were labeled by body mass index (BMI) at prognosis and adopted for as much as 15 years post-prognosis. Sufferers with a BMI of 18.5-24.99 were labeled as long-established, 25-30 were regarded as overweight, and those with a BMI over 30 were categorized as having weight problems.

Most sufferers (74%) were female and indicate baseline age used to be 37.8 years. As neatly as to EDSS, the survey assessed ratings from the Extra than one Sclerosis Affect Scale 29 and the Image Digit Modalities Check.

Obstacles integrated self-reported recordsdata on BMI and doubtless residual confounding from components not accounted for by the survey. BMI alone will most likely be an rotten scientific measure because it doesn’t straight away assess body corpulent.

  • author['full_name']

    Sophie Putka is an project and investigative creator for MedPage As we train time. Her work has seemed within the Wall Avenue Journal, Glance, Industrial Insider, Inverse, Cannabis Wire, and extra. She joined MedPage As we train time in August of 2021. Be aware


Funding for this survey came from the Swedish Study Council, Swedish Brain Basis, and Set aside Stockholm.

Alfredsson did not document disclosures.

Important Source

Americas Committee for Treatment and Study in Extra than one Sclerosis

Source Reference: Alfredsson L, et al “Obesity negatively impacts disease progression, cognitive functioning, and quality of life in of us with a pair of sclerosis” ACTRIMS Forum 2024; abstract CE1.1.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button